The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Affiliation
Leiden University Medical Centre
Country
The Netherlands
Current Status, Position
Dr Kirsten Schimmel is currently Head of the GMP production facility at the Leiden University Medical Centre. The facility has GMP licenses for conventional medicines, ATMPs, small molecules and radiopharmaceuticals. She is also associate professor, responsible for the teaching of Production and Analysis within the Master of Pharmacy at the University of Leiden. Since March 2019, she joined the board of the Dutch Association of Hospital Pharmacists.
Education
Dr Kirsten Schimmel studied pharmacy at the University of Utrecht and became a licensed pharmacist in 1999. She followed her internship in the Academic Hospital of Amsterdam and in 2004, she became a licensed hospital pharmacist. In 2007, she obtained a PhD in Medicine at the University of Leiden for her work on the cytostatic drug cyclopentenyl cytosine.
Research Area
Kirsten Schimmel’s research focuses on drug manufacturing and formulation, implementation of innovative production techniques in compounding strategies.
Conflict of interest: none